BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong Y, Zhou H, Feng H, Zhuang J, Wen T, Zhang C, Sun B, Wang J, Guan Y. Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2. Front Neurosci 2020;14:682. [PMID: 32760240 DOI: 10.3389/fnins.2020.00682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Dai Y, Sa R, Guan F, Wang Q, Li Y, Zhao H. A Purification Method of 18F-FP-(+)-DTBZ via Solid-Phase Extraction With Combined Cartridges. Front Med (Lausanne) 2021;8:693632. [PMID: 34307421 DOI: 10.3389/fmed.2021.693632] [Reference Citation Analysis]
2 Labandeira CM, Fraga-Bau A, Arias Ron D, Muñoz A, Alonso-Losada G, Koukoulis A, Romero-Lopez J, Rodriguez-Perez AI. Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists. Front Neuroendocrinol 2021;62:100914. [PMID: 33845041 DOI: 10.1016/j.yfrne.2021.100914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Alavi SE, Ebrahimi Shahmabadi H. GLP-1 peptide analogs for targeting pancreatic beta cells. Drug Discov Today 2021;26:1936-43. [PMID: 33839290 DOI: 10.1016/j.drudis.2021.03.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]